CureVac Operating Margin 2021-2022 | CVAC
Current and historical operating margin for CureVac (CVAC) over the last 10 years. The current operating profit margin for CureVac as of March 31, 2022 is 0.00%.
|CureVac Operating Margin Historical Data
||TTM Operating Income
||Medical - Biomedical and Genetics
CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.